Courtesy of pfizer.com Pfizer said Friday it will request an emergency-use authorization from the Food and Drug Administration for its coronavirus vaccine candidate. The drugmaker, which is working with German partner BioNTech on the project, is the first to seek authorization for a coronavirus vaccine in the U.S. “Filing in the U.S. represents a critical milestone in our journey to deliver a COVID-19 vaccine...
Read Full Story
Trending News
Trending News